logo

For the Inventor, By the Inventor

Lund, Sweden

Camurus Ab


USPTO Granted Patents = 40



Trademarks = 9

Forward Citations = 285

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Fredrik Tiberg (33 out of 35 patents)

silverMedal Markus Johnsson (32 out of 35 patents)

bronzeMedal Catalin Nistor (12 out of 13 patents)

4.  Fredrik Joabsson (12 out of 13 patents)

5.  Ian Harwigsson (10 out of 11 patents)

6.  Justas Barauskas (7 out of 8 patents)

7.  Krister Thuresson (7 out of 9 patents)

8.  Margareta Linden (3 out of 3 patents)

9.  Markus Johansson (2 out of 3 patents)

10.  Kare V Larsson (2 out of 14 patents)

11.  Britta Siekmann (1 out of 2 patents)

12.  Gert Wörle (1 out of 1 patent)

13.  Heike Bunjes (1 out of 1 patent)

14.  Hakan Hakansson (1 out of 5 patents)

15.  Andreas Norlin (1 out of 1 patent)


Core Competencies:
Buprenorphine
Opioid
Lipid
Controlled Release
Peptide
Somatostatin
Depot
Topical
Pharmaceutical
Antithrombogenic
GLP-1
Bioadhesive

40 patents:

1. 12653819 - Formulations and treatment methods (2026-06-16),
2. 12396944 - Injectable buprenorphine formulation (2025-08-26),
3. 12318379 - Opioid formulations (2025-06-03),
4. 12246055 - Lipid-controlled release compositions (2025-03-11),
5. 12161640 - Opioid formulations (2024-12-10),
6. 12029813 - Injectable buprenorphine formulation (2024-07-09),
7. 11672843 - Somatostatin receptor agonist formulations (2023-06-13),
8. 11564968 - Formulations containing a somatostatin receptor agonist (2023-01-31),
9. 11433120 - Controlled release peptide formulations (2022-09-06),
10. 11369617 - Prostacyclin analogue formulations (2022-06-28),
11. 11241476 - Mixtures and formulations comprising an alkyl ammonium EDTA salt (2022-02-08),
12. 11135264 - Formulations containing a somatostatin receptor agonist (2021-10-05),
13. 11135215 - Opioid formulations (2021-10-05),
14. 11110084 - Opioid formulations (2021-09-07),
15. 10912772 - Opioid formulations (2021-02-09),
Company Overview
Camurus AB is a biotechnology company based in Lund, Sweden, specializing in the development of innovative drug delivery systems and long-acting medications. The company focuses on enhancing the therapeutic efficacy and patient adherence of treatments for various chronic conditions, including pain management and addiction. Camurus leverages its proprietary FluidCrystal® technology platform to create formulations that improve the pharmacokinetics of active pharmaceutical ingredients, aiming to address unmet medical needs in the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Camurus Ab USPTO Patent Assignee Logo
40 Patents

#14 in Lund

#174 in Sweden

#17,048 in the World

Lund, SE
Lund, Sweden

Camurus Ab

Forward Citations = 285

23 inventors:

goldMedal Fredrik Tiberg (33 out of 35 patents)

silverMedal Markus Johnsson (32 out of 35 patents)

bronzeMedal Catalin Nistor (12 out of 13 patents)

4.  Fredrik Joabsson (12 out of 13 patents)

5.  Ian Harwigsson (10 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Camurus Ab. Retrieved from https://idiyas.com/company/camurus-ab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…